In other news
PanTera, the joint venture of medical technology company and particle accelerator specialist IBA and the Belgian nuclear research centre SCK-CEN, has announced groundbreaking for its Actinium Production Centre at Mol. The APC will be a state-of-the-art facility for the production of actinium-225, a promising isotope for targeted alpha therapy in cancer treatment. The building is scheduled to become operational in 2028, with the first commercial supply of Ac-225 expected in 2029.
California-based nuclear startup company Deep Fission, which is proposing to place microreactors deep underground, announced it has signed Letters of Intent with data centres, co-developers, industrial parks, and strategic partners totalling 12.5 GW of power. The LOIs outline plans to pursue commercial deployment of Deep Fission’s SMRs. Deep Fission estimates its model could reduce overall costs by 70-80% compared with traditional nuclear plants, delivering an estimated levelised cost of electricity of 5-7 US cents per kWh.
No comments:
Post a Comment